Johnson Financial Group Inc (Wisconsin)’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-215
Closed -$5.24K 894
2024
Q3
$5.24K Hold
215
﹤0.01% 779
2024
Q2
$5.4K Hold
215
﹤0.01% 608
2024
Q1
$6.43K Sell
215
-15
-7% -$441 ﹤0.01% 581
2023
Q4
$7.32K Sell
230
-995
-81% -$31.2K ﹤0.01% 688
2023
Q3
$43.2K Buy
+1,225
New +$46.7K ﹤0.01% 411

Other funds holding GMAB

Johnson Financial Group Inc (Wisconsin)'s GMAB Position: Q4 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Genmab (GMAB) in Q4 2024, closing a stake of 215 shares — an estimated $5.24K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in GMAB in Q3 2023 and held it in 5 quarters. The position peaked at $43.2K in Q3 2023. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 215 Genmab shares in Q4 2024, an estimated $5.24K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Genmab in Q3 2023 and held it in 5 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Genmab position peaked at $43.2K in Q3 2023.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q4 2024, filed 14 Feb 2025.